A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

In addition, due to increased demand, many GLP-1 agonists are listed on the FDA's Drug Shortages list. People also must consider their comfort level regarding injections, which is the form of ...

Eli Lilly (LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

As concerns around knockoffs of newer GLP-1 drugs like Ozempic and Wegovy take ... t be allowed to place liraglutide on its compounding list given that FDA-approved generics to Victoza are available.

Mounjaro and Zepbound, both containing the drug tirzepatide, are exclusive to Eli Lilly but were temporarily added to the FDA's drug shortage list due ... versions of GLP-1 medications, citing ...

StudyFinds' Dr. Faith Colemans explains why shopping for weight loss drugs online may save you money but endanger your health ...

While the FDA had considered Lilly's (LLY) tirzepatide and Novo Nordisk's (NVO) semaglutide in short supply for months, Lilly's (LLY) products were taken off the shortage list in October.